QuidelOrtho Corp
For the period ended Mar 30, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 30, 2025 · Filed May 8, 2025
QDEL$11.52-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of March, 202 and December
CONSOLIDATED BALANCE SHEETS
(In millions, except par value)
| March 30, 2025 | December 29, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $127.1 | $98.3 |
| Accounts receivable, net | 286.0 | 282.4 |
| Inventories | 563.2 | 533.7 |
| Prepaid expenses and other current assets | 239.8 | 262.4 |
| Assets held for sale | 42.1 | 42.1 |
| Total current assets | 1,258.2 | 1,218.9 |
| Property, plant and equipment, less accumulated depreciation and amortization of $784.7 and $726.2 at March 30, 2025 and December 29, 2024, respectively | 1,399.4 | 1,380.2 |
| Right-of-use assets | 165.0 | 168.7 |
| Goodwill | 670.9 | 649.5 |
| Intangible assets, less accumulated amortization of $767.1 and $718.1 at March 30, 2025 and December 29, 2024, respectively | 2,697.9 | 2,735.6 |
| Other assets | 270.2 | 270.7 |
| Total assets | $6,461.6 | $6,423.6 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $230.9 | $246.0 |
| Accrued payroll and related expenses | 135.3 | 116.9 |
| Income tax payable | 5.8 | 5.4 |
| Current portion of borrowings | 393.8 | 341.8 |
| Other current liabilities | 281.4 | 288.7 |
| Total current liabilities | 1,047.2 | 998.8 |
| Operating lease liabilities | 163.3 | 167.2 |
| Long-term borrowings | 2,105.9 | 2,141.3 |
| Deferred tax liabilities | 78.2 | 76.5 |
| Other liabilities | 69.8 | 55.3 |
| Total liabilities | 3,464.4 | 3,439.1 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at March 30, 2025 and December 29, 2024 | — | — |
| Common stock, $0.001 par value per share; 126.2 shares authorized; 67.5 and 67.3 shares issued and outstanding at March 30, 2025 and December 29, 2024, respectively | 0.1 | 0.1 |
| Additional paid-in capital | 2,897.8 | 2,884.8 |
| Accumulated other comprehensive loss | (23.8) | (36.2) |
| Retained earnings | 123.1 | 135.8 |
| Total stockholders’ equity | 2,997.2 | 2,984.5 |
| Total liabilities and stockholders’ equity | $6,461.6 | $6,423.6 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.